Announcements Trials
Browse Landscape

Phase

Phase 3 3Phase NA 1Phase 4 1Phase 2 1

Status

Unknown 3Not yet recruiting 2Completed 1

Sponsor Class

OTHER 3INDUSTRY 3

Study Type

Interventional 6

Sponsor

Cancer Type

Genitourinary 6

Conditions

Non-Muscle Invasive Bladder Neoplasms 6Urinary Bladder Neoplasms 5Testicular Neoplasms 3Prostatic Neoplasms 2Wilms Tumor 1Upper Tract Urothelial Carcinoma 1Testicular Germ Cell Tumor 1Recurrence 1Ovarian Neoplasms 1Neoplasms, Germ Cell and Embryonal 1Disease Progression 1

Interventions

Gemcitabine 30Mitomycin 26BCG Vaccine 13Docetaxel 10Epirubicin 6erdafitinib 5durvalumab 5dodecyl maltoside 5Radiotherapy 5Cystoscopy 5apaziquone 4ALT-803 4tislelizumab 3disitamab vedotin 35-aminolevulinic acid hexyl ester 3viscum album peptide 2pembrolizumab 2avelumab 2VB4-845 2Therapeutics 2Imiquimod 2Hyaluronic Acid 2Administration, Intravesical 21-phenyl-3,3-dimethyltriazene 2vocimagene amiretrorepvec 1valrubicin 1tremelimumab 1toripalimab 1pirarubicin 1pemigatinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Non-Muscle Invasive Bladder Neoplasms × Epirubicin × Genitourinary × Clear all
NCT07424287 2026-06-02

A Study of Intravesical SHR-1501 Combination With BCG Versus Investigator-selected Chemotherapy in Subjects With BCG-unresponsive NMIBC

Suzhou Suncadia Biopharmaceuticals Co., Ltd.

Phase 3 Not yet recruiting
236 enrolled
Genitourinary

Non-Muscle Invasive Bladder Neoplasms

NCT06227065 2024-01-26

POLO

University of Bern

Phase 2 Not yet recruiting
28 enrolled
Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

NCT05547516 2022-09-21

BL-PDT-RCT

First Affiliated Hospital Xi'an Jiaotong University

Phase NA Unknown
140 enrolled
Genitourinary

Non-Muscle Invasive Bladder Neoplasms

NCT04490993 2022-02-22

ACCRUE

Jiangsu Yahong Meditech Co., Ltd aka Asieris

Phase 3 Unknown
359 enrolled
Genitourinary

Non-Muscle Invasive Bladder Neoplasms

NCT04736394 2022-02-22

ASCERTAIN

Jiangsu Yahong Meditech Co., Ltd aka Asieris

Phase 3 Unknown
800 enrolled
Genitourinary

Non-Muscle Invasive Bladder Neoplasms

NCT02214602 2018-03-22

NMIBCIVT

Mansoura University

Phase 4 Completed
240 enrolled
Genitourinary

Non-Muscle Invasive Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡